Article
In silico and in vitro: identifying new drugs
Registro en:
PAULI, I. et al. In silico and in vitro: identifying new drugs. Current Drug Targets, v. 9, n. 12, p. 1054-1061, 2008.
1873-5592
Autor
Pauli, Ivani
Timmers, Luis Fernando Saraiva Macedo
Caceres, Rafael Andrade
Soares, Milena Botelho Pereira
Azevedo Junior, Walter Filgueira de
Resumen
: Drug development is a high cost and laborious process, requiring a number of tests until a drug is made available in the market. Therefore, the use of methods to screen large number of molecules with less cost is crucial for faster identification of hits and leads. One strategy to identify drug-like molecules is the search for molecules able to interfere with a protein function, since protein interactions control most biological processes. Ideally the use of in silico screenings would make drug development faster and less expensive. Currently, however, the confirmation of biological activity is still needed. Due to the complexity of the task of drug discovery, an integrated and multi-disciplinary approach is ultimately required. Here we discuss examples of drugs developed through a combination of in silico and in vitro strategies. The potential use of these methodologies for the identification of active compounds as well as for early toxicity and bioavailability is also reviewed
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Infografías asignatura Química Farmacéutica 2020
Ávila Illanes, Juan Antonio (2020)La asignatura de Química Farmacéutica representa el primer escalón en el manejo de fármacos, puesto que su enfoque químico, permite entender el diseño y el desarrollo de los mismos, es por esto, que en respuesta al vertiginoso ... -
Obtenção e caracterização de fotocatalisadores baseados nos óxidos de Ti(IV) e W(VI)
Paula, Leonardo Ferreira de